Back to search

Ionis Usa Limited

05508379

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk

No risk factors detected.

Details

TOWER 42, LEVEL 30, 25 OLD BROAD STREET, EC2N 1HQ
Incorporated 14/07/2005

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr. Patrick Ryan O'Neil

secretary · Since 02/08/2011

Mr Matthew Richard Buck

director · Since 10/07/2018

VICE PRESIDENT, REGULATOR AFFAIRS

AMERICAN · UNITED STATES · Age 49

Persons with Significant Control

Ionis Pharmaceuticals, Inc.

75–100% votes

2855, Gazelle Court, Carlsbad, 92010

Notified 06/04/2016

CompanyRankvs 2467+ SIC 72110 peers
36

Financial strength24th percentile among SIC peers · 6/25
Employees0th percentile among SIC peers · 0/15
LiquidityNo balance sheet data · 0/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength6/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees0/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£1

Balance sheet strength

Cash

£1

Cash in the bank

Net Current Assets

Working capital

Current Assets

Current Liabilities

Prepared with Companies House